Heron Therapeutics
HRTX
HRTX
124 hedge funds and large institutions have $1.25B invested in Heron Therapeutics in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 104 → 124 (+20)
9.97% less ownership
Funds ownership: 117.12% → 107.15% (-10%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
124
Holding in Top 10
5
Calls
$14.3M
Puts
$3.32M
Top Buyers
| 1 | +$27.3M | |
| 2 | +$25.4M | |
| 3 | +$23.4M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$10.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.83M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$8.53M | |
| 3 | -$6.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.33M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$5.08M |